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ABSTRACT:
Giant-cell tumors are common around the knee. Proximal tibia is a challenging location for limb-salvage due to 
paucity of soft-tissue cover. Bone cement has been used in treatment of giant-cell tumors after curettage. Tissue 
irritant properties of its monomer and exothermic reaction involved in polymerization may compromise surgical 
outcome to varying degrees. Preoperative planning and intra-operative positioning during cementing process are 
of importance to avoid complications. Co-occurrence of psychiatric illness in tumor patients should be managed by 
psychiatric counselling and drug therapy. This case has been presented to suggest measures for preventing soft-tissue 
complications during cement filling in proximal tibia, and for dealing with concomitant psychiatric problems for a 
holistic improvement in tumor patients.
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Giant-cell tumors of bone are benign tumors 
with aggressive potential. The most common site 
of occurrence is around the knee. Proximal tibia 
giant cell tumors are fairly common, involving the 
medial or the lateral tibial plateau. Intra-lesional 
resection by curettage has a higher recurrence rate, 
but a satisfactory knee function compared to wide 
resection, on a long-term follow up.1 Curettage of 
tumor and filling the cavity with bone cement is an 
accepted procedure for the non-aggressive giant-cell 
tumor.2 Bone cement usage in proximal tibia has 
its own set of complications because of proximity 
of neurovascular structures and sparse soft-tissue 
cover. We present a case, which made us modify 
our treatment approach in managing extensive lytic 
lesions with bone cement filling in proximal tibia. 
A second salvage surgery was required to manage 
the complication of full thickness skin necrosis. The 
presence of co-morbid psychiatric illness especially 
depression, in patients with bone tumors, needs to be 
evaluated and managed effectively for good overall 
outcome.
CASE REPORT:
A 28 year male patient presented to our 
outpatient department complaining of pain and 
swelling around the right knee, gradually increasing 
over a three month period. He had sustained a trivial 
trauma to the affected area six months ago. He was 
prescribed medication for the pain (aceclofenac 100 
mg twice daily for two weeks), by a local physician, 
without much improvement in the severity. He was 
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quite anxious regarding the persistence of pain and 
appearance of swelling. The swelling had grown 
appreciably in size over a period of two weeks 
and he was finding difficulty in climbing stairs 
and squatting. Due to the above symptoms he was 
worried about the possibility of it being a cancerous 
growth. He was sleeping poorly at night; his appetite 
had reduced considerably, and was gradually losing 
interest in his work. On examination a globular, 
bony hard mass was felt on the antero-medial aspect 
of right proximal tibia measuring 3 cm x 3 cm. It 
seemed to be arising from the bone. The overlying 
soft-tissue was non-adherent to the mass. There 
were no scars, sinus, venous prominence, overlying 
the involved area. There were no associated masses 
felt around the knee. Knee flexion was terminally 
restricted. The right lower limb had no neurovascular 
deficit. 
 Radiographs were ordered, which revealed 
an extensive area of lucency, with bony septations 
within the proximal tibia, giving a "soap-bubble" 
appearance (Figure 1). The lucency involved the 
whole of medial condyle and part of lateral condyle 
of right tibia. The tumor had not breached the 
cortex and there was no pathological fracture at 
presentation. Based on these findings a diagnosis of 
giant-cell tumor of the proximal tibia was made. 
 The patient was also referred to a psychiatrist 
for evaluation of his mental status and management 
of any co-morbid psychiatric illness. Psychiatric 
evaluation resulted in the diagnosis of a depressive 
episode as per ICD-10 guidelines. The instrument 
used for assessing the severity of the depressive 
episode was Hamilton Depression Rating Scale 
(HAM-D SCALE). On the first psychiatric 
evaluation, a score of 16 was obtained indicating 
moderate depression. The patient was started on 
tablet escitalopram 10 mg once a day for treatment 
of the depressive episode. 
 The limb was rested in a knee immobiliser. 
An urgent operative intervention was planned, to 
prevent a pathological fracture. Curettage of giant-
cell tumor mass was done through an antero-medial 
approach to proximal tibia, elevating a full-thickness-
skin soft-tissue flap. Sterile water was used to 
lavage the cavity as an adjunct to curettage, for local 
control. The curetted bone cavity was packed with 
approximately 80 gm of polymethylmethacrylate 
(PMMA) bone cement. The choice of PMMA 
was made, to give immediate stability to the 
already weakened proximal tibia, and to utilize the 
tumoricidal (thermal necrosis) properties of PMMA.
Post-operative radiographs showed good position of 
bone cement, supporting the tibial articular surface 
and the medial pillar (Figure 2). 
 On the first post-operative day, localized 
blistering of skin was noticed over the cement 
implanted area. Patient was able to ambulate pain-
free, following the procedure. The skin blister was 
treated by local dressing change. It evolved to 
form an eschar at two weeks, the operative incision 
site healed without complications. On repeated 
dressings, there was no improvement, and no 
spontaneous epithelisation of the eschar area was 
noted. The patient on psychiatric follow up was seen 
to have improved with the prescribed medication. 
The HAM-D score was 10 at four weeks follow-up. 
Anti-depressant medication was continued at the 
Fig 1: Preoperative radiographs of right knee showing extensive 
lytic lesion of proximal tibia. Note the "soap-bubble" appearance 
characteristoc of giant cell tumour.
Fig 2: Postoperative Antero-pos-
terior radiograph of right knee 
showing good articular and medi-
al pillar stability provided by bone 
cement.
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same dosage and follow up was advised.
 The eschar detached at four weeks, leaving 
a circular full-thickness skin and soft-tissue defect, 
measuring 5 cm x 5 cm. The base of this defect 
was formed by the implanted bone cement (Figure 
3). At this stage, radiographs showed good cement 
position in the cavity, no lucency and no detachment 
at cement-bone interface was noted. A decision was 
made to cover the bare implant surface by a second 
surgery. Medial gastrocnemius rotation flap, with 
split-thickness skin graft was done to salvage the 
situation (Figure 4). The defect area healed well 
over a one-month period (Figure 5). Psychiatric 
evaluation at this time showed that severity of the 
depressive episode had reduced considerably with 
a HAM–D score of eight. Tab escitalopram was 
continued at the same dose of 10 mg per day for 
another four months with regular OPD follow-ups. 
 At one year follow up, there was no recurrence 
of the tumor noted, there were no metastases, the 
bone cement was supporting the tibial articular 
surface well, and the patient was symptom free, with 
satisfactory knee function. The patent did not show 
any symptoms of a mood disorder at one year follow 
up.
DISCUSSION:
 Giant-cell tumor of bone has been classified 
as benign tumor with a potential of becoming 
aggressive. The most common site of occurrence 
is the knee area, involving the distal femur and the 
proximal tibia. Various methods of management 
of this lesion have been reported in literature 
depending upon the amount of bone destruction, 
the location of tumor and the aggressiveness of the 
tumor. One of the modality of treatment is curettage 
of the tumor cavity and packing it with PMMA bone 
cement. PMMA is biologically compatible, provides 
immediate stability to the applied area, and in 
addition has tumoricidal effect due to the exothermic 
reaction involved in its polymerisation.2 There are 
complications reported in literature with the use of 
bone cement. Thermal damage to adjacent soft-tissue 
structures including nerves and vessels, in various 
locations has been reported. Cement burns following 
Total Hip Replacement surgery involving obturator 
nerve, sciatic nerve, femoral nerve, ureter, and 
intrapelvic arteries can occur as serious unforeseen 
complications of a reconstructive surgery.3-7 Skin and 
soft-tissue necrosis from discarded bone cement has 
been reported.8 Embolism, allergic reactions, venous 
leakage, hypotension and rarely cardiac arrest have 
been encountered with usage of bone cement, both 
intraoperatively and after percutaneous injections. 
The systemic effects have been attributed to the 
absorbed methacrylate monomer.9 The local effects 
have been related to the heat of polymerisation 
causing coagulation of proteins, occlusion of 
metaphyseal arteries producing bone necrosis, and 
lipolytic and cytotoxic effects of unpolymerised 
monomer.10 
 Bone cement has been used in skeletal 
metastases to relieve pain. The process of 
cementoplasty in such long bone and vertebral 
lesions, leads to local extrusion and soft-tissue 
damage. The extent of damage due to bone cement 
Fig 3: The full thickness soft tissue defect over the anteromedial 
portion of proximal tibia. The base is formed by the implanted 
bone cement. The operative scar site has healed normally.
Fig 4: Intraoperative photograph showing medial gastrocnemius 
rotation flap covering the soft tissue defect. 
Fig 5: Skin-soft tissue defect healed after medial gastrocnemius 
rotation flap and split-thickness skin graft application.
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has not been quantified and may have been considered 
insignificant in relation to the short life expectancy of 
such patients.11 But the scenario can be of immense 
importance in association with tumors with near-
normal life expectancy, such as Giant-cell tumors. 
These situations are different from cementoplasty and 
vertebroplasty cases in which the amount of cement 
used is in small quantities, and the primary purpose 
is relief of bone pain. Use of cement in arthroplasty 
for stabilization of components is also not to the 
amount used in filling extensive bone cavities, 
post-curettage. The bone cement is made of a white 
powder, consisting of polymethylmethacrylate, 
methyl methacrylate-styrenecopolymer and barium 
sulphate, with a flammable liquid monomer 
composed of methyl methacrylate, NN-dimethyl-p-
toluidine, and hydroquinone.11 On mixing the white 
powder with the liquid monomer, dough is formed, 
as the monomer starts to polymerize. The setting time 
is usually 6-10 minutes depending upon the ambient 
temperature and the initial temperature of the bone 
cement components, cooling helps prolong the 
setting time. Nearly 13 kcal (55 kJ) of heat is evolved 
in polymerization of 100 gms of bone cement.5 The 
temperatures can reach 100 degree centigrade in a 
laboratory setting, although in vivo the temperatures 
range between 38 degrees to 56 degrees centigrade 
for arthroplasty patients with a 2-3 mm thick cement 
mantle.12-14 The surface temperature of setting cement 
varies with setting time and thickness of cement, 
with a 10 mm specimen reaching 107°C at room 
temperature (25°C).15 Even when the dough is ready 
for insertion, there is 4% of unutilised monomer in 
the mixture.9 The percentage becomes significant 
if 80 grams or more of cement are used for the 
procedure, which increases the amount of unutilised 
monomer as well. In the past the thermal necrosis 
properties of bone cement have been studied and 
many soft tissue burns ascribed to it. There exists a 
co-component to the soft-tissue damage due to bone 
cement, which is the unutilised methylmethacrylate 
monomer, and causes chemical necrosis. As seen in 
our case, despite taking all precautions, regarding 
full thickness skin flap for the exposure of tumor, 
proper curettage and cement packing and cooling of 
the cement before suturing the flap back in place, 
full-thickness skin and soft-tissue necrosis did occur. 
This might have been due to contact thermal necrosis 
and chemical necrosis properties of PMMA. In a 
report by Arumilli BRB, Paul AS, the full-thickness 
skin and soft-tissue necrosis occurred opposite to 
the incision site.16 This non-contact thermal necrosis 
was ascribed to extensive exothermic reaction and 
thermal conductivity of underlying bone. It was 
emphasized in this report, that if anterior approach 
is used for curettage and bone cement application, 
"There might be noncontact thermal necrosis of soft 
tissues posterior to the intact proximal tibia that 
might go undetected and could cause catastrophic 
neurovascular complicaions". This observation may 
be true, and as an addition to this we would like to 
emphasize modifications which might help avoid 
chemico-thermal necrosis of soft-tissue around 
proximal tibia. The first one would be regarding 
the position of the leg during cement application 
and setting. In the case report with non-contact 
thermal necrosis,the patient was positioned prone 
for a prolonged period, so this probably allowed the 
unutilised monomer to gravitate through the haversian 
system and damage tissues opposite (anterior) to the 
site of application of cement (posterior), causing non-
contact necrosis.16 In the anterior approach, when the 
patient is in supine or lateral position, we believe that 
after the cement has been filled in the cavity of tibia, 
the knee should be bent to 90 degree, if possible, to 
let the neurovascular structures fall-back away from 
proximal tibia. The second one would be regarding 
the position of cortical window for tumor curettage. 
A pre-operative axial CT scan of the involved tibia 
can be of help. The window should be made in the 
thinnest cortex and should have the thickest cortex 
as its floor, to withstand the pressurizing of cement, 
invaginations in cancellous bone, and distribute 
(soak) the gravitating liquid monomer in many 
channels of haversian system, preventing focal 
accumulations, and soft-tissue burns. To achieve 
this, the patient should be positioned lateral, with 
the involved knee up, in case of predominant lateral 
condylar lytic tumor. For predominantly medial 
tibial condylar involvement; the patient should be 
positioned supine, and cementing done in a figure-
of-four position of the involved knee. The thinner 
the bone around the curetted cavity, higher is the 
chances of soft-tissue complications following bone 
cement application. 
 The rate of depressive disorders in somatic 
illnesses varies between 10 – 40 percent. Hence, it is 
important to diagnose this psychiatric co-morbidity 
at the earliest and start anti-depressant treatment 
in such patients.17 Amongst the selective serotonin 
reuptake inhibitors (SSRIs), escitalopram has shown 
to be superior both in efficacy as well as safety 
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profile.18,19 It has also got minimal drug interactions 
and is well tolerated in the majority of patients.
CONCLUSION:
 Giant-cell tumors in proximal tibia with 
extensive lysis at presentation can be a challenging 
situation in limb salvage surgery. The options for 
reconstruction are limited. Autogenous bone graft 
is limited in quantity and there is uncertainty about 
its consolidation, with a risk of pathological fracture 
during the process of healing. PMMA bone cement 
is required in large quantities, does not cause donor 
site morbidity, prevents pathological fracture from 
occurring, and results in satisfactory knee movement 
preservation. The amount of damage to soft-tissues 
following bone cement filling in large tumor cavities 
of proximal tibia, can be to a larger extent due to 
increased amount of cement used. This can cause 
more thermal necrosis and more chemical necrosis, 
in a confined space of proximal tibia with meagre 
muscle and fat cover to dissipate heat, and increased 
chances of damage to neurovascular structures 
around the knee. Care is advised regarding planning 
of the position of patient, position of cortical 
window for curettage and position of knee during the 
polymerization phase of bone cementing, to avoid 
disastrous complications. The suspicion and hence 
the early diagnosis and treatment of depressive 
episode in this patient played a significant role in 
the favorable outcome of the surgical procedures. 
The improvement of mood and reduction in feelings 
of despair and pessimism with anti-depressant 
medication and supportive psychotherapy helped 
the patient to go through the second procedure with 
hope and confidence.
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